The late study of Ferrajoli et al. (2002) used TNF-α as a tumorigenesis biomarker and associated its elevated plasma level with varying stages of tumour progression and metastasis in chronic lymphocytic leukaemia. This evidence concerns the gene TNF and neoplasm.